Literature DB >> 1772342

5-Hydroxytryptamine-induced contraction of human isolated umbilical artery and its dependence on cellular and extracellular Ca++.

N Doğan1, E Ciçek, A G Cenik, E Singirik, M Kiliç, A S Ozcan.   

Abstract

The contribution of intra- and extracellular Ca++ during KCl- and 5-hydroxytryptamine-induced contractions was investigated in human isolated umbilical arteries obtained from cords of normal full-term deliveries. In normal solution, nifedipine caused dose-dependent relaxations of the arteries contracted by high K+ (80 mM) and 5-hydroxytryptamine. The IC50 value of nifedipine on KCl-induced contractions was about 9 times lower than that on 5-hydroxytryptamine-induced contractions. In Ca(++)-free medium, KCl failed to induce contractions of the artery. However, 5-hydroxytryptamine caused contractions amounting to 52% of the maximum response obtained by re-addition of Ca++, and this response was abolished by 10(-6) M of nifedipine. In the presence of either KCl or 5-hydroxytryptamine, subsequent addition of Ca++ caused reproducible contractions which were also inhibited by nifedipine. These results indicate that the KCl-induced contraction of human isolated umbilical artery is mainly dependent on extracellular Ca++, whereas that induced by 5-hydroxytryptamine involves both intra- and extracellular Ca++. It is also suggested that nifedipine does not only inhibit the influx of extracellular Ca++ during the contraction by 5-hydroxytryptamine but that it may also have intracellular effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1772342

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  1 in total

1.  Genistein effects on Ca2+ handling in human umbilical artery: inhibition of sarcoplasmic reticulum Ca2+ release and of voltage-operated Ca2+ channels.

Authors:  F Speroni; A Rebolledo; S Salemme; R Roldán-Palomo; L Rimorini; M C Añón; A Spinillo; F Tanzi; V Milesi
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.